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Introduction
Umbilical cord blood (UCB) is a valuable source of
more better studied hematopoietic stem cells with a
wide application in cell-based therapy [1-6]. Addition-
ally, UCB is also a source of non-hematopoietic cells
called mesenchymal stem cells (MSC) [7-9]. They are
adherent cells with a morphology similar to fibroblast
cells and an expression of a characteristic panel of sur-
face markers and which lack the expression of CD 34
antigen. These cells - with their ability to differentiate
into such tissue types as bone, cartilage, fat, muscle
and probably also nervous - constitute an attractive
alternative source of mesenchymal stem cells of a high
therapeutical potential.
Mesenchymal stem cells which are CD34 negative
have not only the ability to differentiate into different
types of tissues, but they can also self-replicate, which
is one of the fundamental properties of a stem cell.
Studies concentrating on finding the molecular basis
of proliferating properties led to the discovery of the
Oct3/4 transcriptive factor [10], LIF activating Stat3
[11-13] and Nanog [14,15] in embryonic stem cells.
Nowadays more better studies are based on the
analysis of genes expression using oligonucleotide
microarrays which leads to defining the so-called stem
cell molecular signature [16,17]. The proliferating
potential of CD 34- stem cells - as well as other stem
cells - is sustained by suitably activated constellations
of genes; however, as of today, no unambiguously
determined molecular factor responsible for SC self-
replication has been found.
Having in mind the above, the authors decided to
compare two populations of adherent and non-adher-
ent CD 34- cells derived from umbilical cord blood.
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Abstract: One of the more interesting cells present in the umbilical cord blood - as far as their potential clinical use is con-
cerned - are stem cells not presenting the CD34 antigen.. These are the pluripotential cells with their biological properties
similar to mesenchymal stem cells, with the ability to differentiate into such tissue types as bone, cartilage, nervous (to some
extent), glia and muscle. The authors compared the activity of genes coding the proteins in mitogenic signal paths activat-
ed by kinin receptors using oligonucleotide microarrays in adherent and non-adherent CD 34- cells derived from umbilical
cord blood. In the linear regression model with a 95% prognosis area for differentiating genes outside this area, the follow-
ing genes were selected: c-jun (present in 3 isoforms) and c-fos. The fos and jun genes create the AP-1 transcriptive factor
which regulates the expression of genes taking part in numerous cellular processes, including the cell cycle and mitosis. The
obtained results shed some light on the molecular processes behind the MSC proliferation and are a starting point for fur-
ther studies on the mesenchymal stem cell biology. 
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The authors compared the activity of genes coding the
proteins of mitogenic signal paths activated by kinin
receptors using oligonucleotide microarrays. Kinin
receptors are numerously found in human cells and -
among others - also play a role in the regulation of
cells proliferation. 
Knowing that mesenchymal stem cells are adherent
and have a high proliferating potential, the authors
looked for a molecular factor in the mitogenic kinin
path which would better characterize this population
of cells and which would become the mesenchymal
stem cell signature and as a result help better under-
stand the mechanisms controlling the proliferating
process of the CD 34- stem cells.
Materials and methods
The material for studying the expression of genes using oligonu-
cleotide microarrays consisted of cultures of CD34- cells with dif-
ferent adhesive properties. The adherent cells were marked CD34-
P, while the non-adherent - CD34-NP. Total RNA was extracted
from the cultures.
Extraction of CD 34-cells from umbilical blood. The collected
umbilical blood was diluted with PBS (Gibco) and then carefully
layered on Ficoll at the ratio of 2:1 and centrifuged for 40 min. at
400 x G in 20°C. The obtained lymphocytic surface coat was sus-
pended in medium with an addition of serum and centrifuged again
for 10 min. at 200 x G in 20°C. This action was repeated twice. The
cells were divided into CD34+ and CD34- fractions with the
Progenotor Cell Isolation Kit and the Mini&MidiMACS Starting
Kit. The CD34 cells count was performed by the cells fluorescence
check upon the incubation with monoclonal antibodies anti-CD34
(BD) coupled with IgG1 (BD) antibodies. Cells' vitality was
assessed with a fluorescence microscope upon their marking with
etidine bromide and acridine orange. The CD34 cells count was
performed with flow cytometry upon incubation with monoclonal
antibodies anti-CD34 (BD) coupled with phycoerythrin (PE) or
with IgG1 antibodies. The analysis was performed with FACSCal-
ibur (BD) and CELLQuest (BD) software. 
Culture establishment. The isolated fractions were used to start
cultures in expansion medium. Cells were allowed to adhere
overnight and nonadherent cells were washed out and cultured sep-
arately in new flasks. Medium changes were carried out once a
week thereafter. Expansion medium consists of Iscove modified
Dulbecco medium (IMDM) and 20% fetal bovine serum (FBS)
supplemented with 10 ng/mL bFGF, 100 U penicillin, 1000 U
streptomycin, and 2 mM L-glutamine (Gibco). 
Total RNA extraction from cell culture. RNA extraction from
CD34 cell culture was performed with a total RNA extraction kit
(Total RNA Prep Plus, A&A Biotechnology) based on the modified
Chomczynski and Sacchi method (Chomczyñski P, Sacchi N,
1987). In the initial phase, cells were diluted and the endogenic
RNases inactivated with phenol. After the addition of chloroform,
the mixture was centrifuged and the TNA was precipitated with
isopropanol. Next the mixture was centrifuged for 20 min. at 13
000 rpm, the supernatant was decanted and the RNA sediment was
washed twice with 75% ethanol. Upon drying, the sediment was
stored at -70°C until analysis. 
RNA extracts quality analysis. RNA extracts were quality
assessed with agar electrophoresis in 1% agar gel with an addition
of etidine bromide (0.5 mg/ml) in the SUBMINI device (Kuchar-
czyk). 5 μl of extract was mixed with 3 ml of loading solution
(0.05% w/v bromophenol blue, 60% glycerol) and warmed at 65°C
for 4 min. Upon separation, electrophoregrams were assessed with
the UV transilluminator (λ=260 nm).
RNA extracts quantity analysis. Total RNA extracts were
assessed with the spectrophotometric assessment of RNA concen-
tration (Gene Quant II, Pharmacia). The spectrophotometric
assessment of extracts included the absorbency check with wave
lengths of 230, 260, 280 and 320 nm, and next the determination
of the A260/A280 ratio and protein contents. The absorbency value
for the wale length of 260 nm was used to determine the RNA con-
centration, assuming that the result in a cuvette of optic path of 1
cm equal 1 OD260 corresponds to the concentration of 40 mg of
RNA per 1 cm3 of extract.
Microarrays - methodology 
General assumptions. The studied material consisted of TNA
extracted from cell cultures with the TRIzol reagent. The isolated
RNA was then purified with RNeasy Total RNA Mini Kit and
etched with DNasis. Approximately 8 μg of total RNA was used
for the synthesis of two-thread cDNA. It was followed by the
cRNA synthesis, marked with biotin. Biotinized cRNA was then
fragmented and hybridized with Test3 and HG U133A microarrays
(Affymetrix) and marked with the streptavidin-phycoerythrin com-
plex. The fluorescence intensity was analyzed with the GeneArray
Scanner G2500A. The quantity and quality of total RNA, cDNA
and cRNA were assessed spectrophotometrically and with elec-
trophoresis in 1% agar gel. The obtained results were analyzed
with RMA Express and Luster 3.0 software.
Stage I
Purification of RNA extract with RNase Mini Kit. Upon meas-
uring the concentration of the RNA extract, it was brought to the
volume of 100 μl with RNase-free water; next, 350 μl of RLT
buffer with β-mercaptoethanol and 250 μl of 96% ethanol was
added, the mixture was stirred by pipetting, and then placed on a
column and centrifuged for 15 seconds at 12 000 rpm. The filtrate
was discarded and the column placed in a new tube; 350 μl of RW1
was added and then centrifuged for 15 seconds at 10 000-12 000
rpm. The next stage consisted of etching with DNase. 70 μl of
RDD buffer was added to a tube containing 10 μl of DNase. The
mixture was placed on a column membrane and left etching for 15
min. in room temperature. Next, 350 μl of RW1 was added, the old
filtrate was drenched and centrifuged for 15 seconds at 12 000 rpm.
The filtrate was discarded and 500 μl of RPE was added on the col-
umn. The extract was centrifuged for 1 minute at 14 000 rpm, then
the column was rotated and the centrifuging was repeated in the
same conditions. Upon centrifuging, the column was moved to a
new tube, 30 μl of H2O was added and left for 10 minutes. Upon
centrifuging, 20 μl H2O was added, left for a few minutes and cen-
trifuged again. Upon purification, the concentration of obtained
extracts was assessed. 
cDNA synthesis 
1st thread synthesis. In order to obtain the first cDNA thread, 10
μl of RNA extract was mixed with 2  l of 100 pM starter T7-oligo
(dT)24 (5'-GCC AGT GAA TTG TAA TAC GAC TCA CTA TAG
GGA GGC GG-3'); the mixture was incubated at 70°C for 10 min-
utes and placed on ice. Next, the following were added to the reac-
tion: 4 μl of 5× First Strand Buffer, 2 μl of 0.1 M DTT and 1 μl of
10 mM dNTPs. Upon 2 minutes of preincubation at 45°C, 1 μl
(200 U) of reverse transcriptase Supercscript II (Life Technologies)
was added to the mixture and incubated for another hour. 
2nd thread synthesis. In order to obtain the second cDNA thread,
30 μl of 5× Second Strand Buffer, 91 μl of RNase-free water, 3 μl
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of 10 mM dNTPs, 4 μl (40 U) of E. coli DNA Polymerase I, 1 μl
(10 U) of E. coli DNA Ligase and 1  l (2U) of RNase H were added
to the mixture. The mixture was incubated for 2 hours at 16°C.
Next 2.5 μl (10 U) of T4 DNA Polymerase I was added to the mix-
ture and incubated at 16°C for another 5 minutes. The reaction was
stopped by adding 10 μl of 0.5 M EDTA and the two-thread cDNA
was extracted with the phenol/chloroform method. The liquid
phase was separated with Phase Lock Gel tubes.
Stage II
Precipitation. Upon night-long freezing at -20°C, 0.3 μl of Palet
Paint was added top the mixture and centrifuged for 20 min. at
12000 rpm. in room temperature; the supernatant was collected and
the sediment was washed twice with 70% ethanol (500 μl) and cen-
trifuged for 5 min. at 12 000 rpm; the sediment was well dried and
diluted in 12 μl. 
cRNA synthesis. The template for biotinylated cRNA synthesis
was 10 μl of ds cDNA to which the following were added: 12 μl of
RNase-free water, 4 μl of hybridization buffer, 4 μl of  ribonu-
cleotides marked with biotin, 4 μl of DTT, 4 μl of RNases inhibitor
and 2 μl of T7 polymerase. The mixture was placed at 37°C for 5
hours and stirred every 30 min.
cRNA purification. Upon 5 hours of incubation, cRNA was puri-
fied. 60 μl of H2O, 350 μl of RLT buffer and 250 μl of 96%
ethanol were added to 40 μl of mixture. The new mixture was
then placed on a column and centrifuged twice for 15 seconds at
10 000 rpm. Next 500 μl of RPE buffer was added on the column
and centrifuged twice for 15 seconds at 10 000 rpm. The column
was incubated with water and then the concentration of cRNA
was assessed.
Stage III
cRNA fragmentation. 16 μg of cRNA was used for fragmentation.
The mixture was centrifuged and placed at 94°C for 35 min. and
then placed on ice. The result of fragmentation was checked on 1%
agar gel.
Assessment of cDNA synthesis, biotinylated cRNA and cRNA
upon fragmentation with the electrophoresis technique in agar
gel. The regularity of cDNA synthesis, biotinylated cRNA and
cRNA upon fragmentation was assessed with electrophoresis in
agar gel with an addition of etidine bromide. The obtained elec-
trophoregram of distribution of above-mentioned products made it
possible to proceed to the next stage of analysis.
Preparation of hybridization cocktail. To prepare the hybridiza-
tion cocktail, 37.5 μl of fragmented cRNA was used and the fol-
lowing were added: 5 μl of hybridization control B2, 15 μl of
eukaryotic control, 3 μl of  Herring Sperm, 3 μl of acetylated BSA,
150 μl of hybridization buffer and 86.5 μl of water. The cocktail
was warmed for 5 minutes at 99°C, 5 minutes at 45°C and cen-
trifuged for 5 minutes at 14 000 rpm.
Application of the cocktail on the chip. The microarray was
warmed to the room temperature and then 100 μl 1× of hybridiza-
tion buffer was applied. The microarray was placed in the
hybridization oven for 10 minutes. Next, the buffer was removed
from the microarray and 200 μl of the hybridization cocktail was
applied. The microarray was placed in the hybridization oven for
16 hours at 45°C.
Stage IV
Rinsing of microarray. After the 16-hour hybridization the
microarray was rinsed and scanned with the GeneArray Scanner
G2500A.
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Fig. 1. Grouping of the stem cell cultures on the basis of the
expression profile analysis of 120 transcripts of genes coding pep-
tides of mitogenic signal paths activated by the receptors for
kinins.  
Results
The genes expression profile (transcriptom) for two
adherent and two non-adherent stem cells was marked
with the oligonucleotide microarray technique
HG_U133A (Affymetrix). 
Literature reports were used to determine the num-
bers of transcripts of the so-called ID genes that code
the peptides of the mitogenic signal paths activated by
the receptors for kinins from 22283 transcripts, whose
transcription activity can be analyzed by means of the
oligonucleotide microarray HG_U133A Affymetrix.
Out of the group of mRNA genes that code peptides of
mitogenic signal paths activated by the receptors for
kinins, 120 transcripts were selected for further study. 
The fluorescence signal of the analyzed transcripts
was a base for defining the transcriptive activity pro-
file of the genes in the four cultures of stem cells. The
genes expression profile marked by means of the
oligonucleotide microarray technique was analyzed
after standardizing the fluorescence values for all ana-
lyzed experiments where the RNA express program
was applied. The results obtained through the oligonu-
cleotide microarray technique were grouped with the
Cluster 3.0 software through the hierarchical clusteri-
zation method, using the Euclidean distance measure
and the agglomeration method: average connections.  
Next, in order to determine the genes differentiat-
ing the cultures of adherent and non-adherent stem
cells, the model of linear regression was established.
By means of this method two genes were determined
to code the transcription factors cjun and fos.
Discussion
The enthusiasm around the mesenchymal stem cell
resulting from its special characteristics, such as a high
proliferation potential, relatively easy isolation, genet-
ic stability, repeatable characteristics in different labo-
ratories, its regeneration ability in the environment of
different tissues makes the MSC a population of
choice for widely-understood tissue engineering. The
fundamental condition for the full exploitation of the
MSC CD34- biological potential lays in the ability to
maintain their culture in a state of non-differentiation,
i.e. in a primitive, pluripotential state, as well as the
ability of their multiplication and orientation of their
differentiation into a chosen tissue. 
However, the level of knowledge of the MSC
remains insufficient. The application of this cell popu-
lation for clinical purposes requires a deeper under-
standing of the mechanisms of its basic processes,
such as self-replication vs. differentiation.
The microarray provides the possibility of studying
the expression of not only one gene during one exper-
iment, but also tens of thousands of genes simultane-
ously. This enables to obtain the total picture of the
condition of the cell at any given moment and also pro-
vides an insight into the regulatory mechanisms of the
cell.
During the laboratory proceedings, the adherent
CD 34- cells, which correspond to MSC in terms of
phenotype, showed a change of the transcriptive activ-
ity of c-jun and fos genes, which - in a determined lin-
ear regression model with a 95% prognostic area -
diversified both cell populations. C-jun and c-fos
genes are protooncogenes, also defined as the immedi-
ate-early genes, because their expression is early
induced as a response to a wide spectrum of stimulat-
ing factors to facilitate a cell's adaptation to the envi-
ronment [18,19]. The fos and jun genes together create
the dimeric complex AP-1. Being a transcriptive factor
through the activation and inhibition of the wide spec-
trum of genes, AP-1 regulates numerous physiological
processes, including - first and foremost - cell prolifer-
ation, differentiation and organogenesis [20,21]. It is
also a necessary factor of various pathological process-
es, e.g. tumorogenesis [22,23].
However, the actual role of the c-fos and c-jun
genes in the MSC has not been defined so far. The
studies conveyed on the mouse embryonic stem cells
where both copies of c-fos were inactivated showed
that there were no changes in viability, proliferating
potential and differentiation of these cells [24,25].
Similarly, the inactivation of both copies of c-jun gene
in the mouse embryonic stem cells via homological
recombination did not show any significant differences
in the process of proliferation and differentiation. Yet,
the same study showed that subcutaneous application
of such recombined mouse embryonic stem cells led to
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Table 1. The symbol and ID of Two genes differentiating the adherent cells from the non-adherent ones.
a drastic reduction in the creation of malignant ter-
atomas [26]. 
To sum up, according to available sources, the sig-
nificance of activity of the genes taking part in the MSC
mitogenic kinin path has not been studied yet. Therefore
the role and significance of the fos and jun genes in the
process of proliferation and differentiation of human
MSC requires further investigation and study.
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